Ciongoli Gregory Austin's Form 4 filing
REGENXBIO Inc. (RGNX) · filed Aug 27, 2026
- Accession no.
- 0002023732-26-000008
- Filed
- Aug 27, 2026, 7:03 PM ET
- Trade date
- Aug 25-27, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market purchases total $949.4K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Ciongoli Gregory AustinCIK 0002023732 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 25, 2026 | Common Stock | AGrant or awardAcquired | +15,432 | $0.00 | $0 | 15,432 | Direct | |
| Aug 26, 2026 | Common Stock | PPurchaseAcquired | +49,196 | $9.14 | +$449,705.56 | 64,628 | Direct | |
| Aug 27, 2026 | Common Stock | PPurchaseAcquired | +53,407 | $9.36 | +$499,675.89 | 118,035 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 25, 2026 | Common Stock | AGrant or awardAcquired | +69,609 | $0.00 | $0 | 69,609 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.